Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Non-cash Items (2023 - 2025)

Mangoceuticals' Non-cash Items history spans 3 years, with the latest figure at $654444.0 for Q3 2025.

  • For Q3 2025, Non-cash Items rose 381.8% year-over-year to $654444.0; the TTM value through Sep 2025 reached $654444.0, up 381.8%, while the annual FY2024 figure was $140833.0, 20.28% down from the prior year.
  • Non-cash Items for Q3 2025 was $654444.0 at Mangoceuticals, up from $150833.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.0 million in Q2 2024 and bottomed at $135833.0 in Q3 2024.
  • The 3-year median for Non-cash Items is $261249.5 (2023), against an average of $512991.7.
  • The largest annual shift saw Non-cash Items surged 472.29% in 2024 before it crashed 92.38% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $176666.0 in 2023, then decreased by 20.28% to $140833.0 in 2024, then surged by 364.7% to $654444.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Non-cash Items are $654444.0 (Q3 2025), $150833.0 (Q2 2025), and $145833.0 (Q1 2025).